⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTX News
Context Therapeutics Inc. Common Stock
Form 8-K
sec.gov
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
CNTX
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CNTX
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
globenewswire.com
ONCY
IMNM
PRLD
CNTX
RLAY
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
globenewswire.com
CNTX
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
globenewswire.com
CNTX
Context Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
CNTX
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
globenewswire.com
CNTX
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CNTX